– Data presented at European Society of Gene & Cell Therapy (ESGCT) Congress 2022 – – Receptor findings support potential for human translation of Voyager’s capsids and may help overcome barriers to CNS drug delivery – CAMBRIDGE, Mass. , Oct. 11, 2022 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc.

Reader Interactions

Leave A Reply